Literature DB >> 8413613

Sphingosine-1-phosphate as second messenger in cell proliferation induced by PDGF and FCS mitogens.

A Olivera1, S Spiegel.   

Abstract

Growth signalling networks that use glycerophospholipid metabolites as second messengers have been well characterized, but less is known of the second messengers derived from sphingolipids, another major class of membrane lipids. A tantalizing link between sphingolipids and cellular proliferation has emerged from the discovery that the sphingolipid metabolites sphingosine and sphingosine-1-phosphate stimulate growth of quiescent Swiss 3T3 fibroblasts by a pathway that is independent of protein kinase C. Sphingosine-1-phosphate is rapidly produced from sphingosine and may mediate its biological effects. Furthermore, sphingosine-1-phosphate triggers the dual signal transduction pathways of calcium mobilization and activation of phospholipase D, prominent events in the control of cellular proliferation. Here we report that activation of sphingosine kinase and the formation of sphingosine-1-phosphate are important in the signal transduction pathways activated by the potent mitogens platelet-derived growth factor (PDGF) and fetal calf serum (FCS).

Entities:  

Mesh:

Substances:

Year:  1993        PMID: 8413613     DOI: 10.1038/365557a0

Source DB:  PubMed          Journal:  Nature        ISSN: 0028-0836            Impact factor:   49.962


  223 in total

1.  Involvement of sphingosine 1-phosphate in nerve growth factor-mediated neuronal survival and differentiation.

Authors:  L C Edsall; G G Pirianov; S Spiegel
Journal:  J Neurosci       Date:  1997-09-15       Impact factor: 6.167

2.  Neutral sphingomyelinase activation precedes NADPH oxidase-dependent damage in neurons exposed to the proinflammatory cytokine tumor necrosis factor-α.

Authors:  Brian M Barth; Sally J Gustafson; Thomas B Kuhn
Journal:  J Neurosci Res       Date:  2011-09-19       Impact factor: 4.164

3.  Inhibitory regulation of Rac activation, membrane ruffling, and cell migration by the G protein-coupled sphingosine-1-phosphate receptor EDG5 but not EDG1 or EDG3.

Authors:  H Okamoto; N Takuwa; T Yokomizo; N Sugimoto; S Sakurada; H Shigematsu; Y Takuwa
Journal:  Mol Cell Biol       Date:  2000-12       Impact factor: 4.272

Review 4.  The therapeutic potential of modulating the ceramide/sphingomyelin pathway.

Authors:  Richard Kolesnick
Journal:  J Clin Invest       Date:  2002-07       Impact factor: 14.808

Review 5.  Pharmacological tools for lysophospholipid GPCRs: development of agonists and antagonists for LPA and S1P receptors.

Authors:  Dong-Soon Im
Journal:  Acta Pharmacol Sin       Date:  2010-08-23       Impact factor: 6.150

6.  Sphingolipid signaling and treatment during remodeling of the uninfarcted ventricular wall after myocardial infarction.

Authors:  Che-Chung Yeh; Hongzhe Li; Deepak Malhotra; Mei-Chuan Huang; Bo-Qing Zhu; Edward J Goetzl; Donald A Vessey; Joel S Karliner; Michael J Mann
Journal:  Am J Physiol Heart Circ Physiol       Date:  2009-02-20       Impact factor: 4.733

7.  Expression of SphK1 impairs degranulation and motility of RBL-2H3 mast cells by desensitizing S1P receptors.

Authors:  Puneet S Jolly; Meryem Bektas; Kenneth R Watterson; Heidi Sankala; Shawn G Payne; Sheldon Milstien; Sarah Spiegel
Journal:  Blood       Date:  2005-03-01       Impact factor: 22.113

Review 8.  Sphingosine-1-phosphate in chronic intestinal inflammation and cancer.

Authors:  Masayuki Nagahashi; Nitai C Hait; Michael Maceyka; Dorit Avni; Kazuaki Takabe; Sheldon Milstien; Sarah Spiegel
Journal:  Adv Biol Regul       Date:  2013-10-16

9.  Intracellular calcium mobilization and phospholipid degradation in sphingosylphosphorylcholine-stimulated human airway epithelial cells.

Authors:  S Orlati; A M Porcelli; S Hrelia; A Lorenzini; M Rugolo
Journal:  Biochem J       Date:  1998-09-15       Impact factor: 3.857

Review 10.  Sphingolipids and cell signalling.

Authors:  P Fredman
Journal:  J Inherit Metab Dis       Date:  1998-08       Impact factor: 4.982

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.